Anaptysbio Book Value Per Share Growth & History (ANAB)
Anaptysbio's book value per share was $1.33 for fiscal 2025.
View full Anaptysbio company overviewAnaptysbio annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.33 | -$1.00 | −42.90% |
| 2024 | 2024-12-31 | $2.33 | -$0.99 | −29.79% |
| 2023 | 2023-12-31 | $3.31 | -$5.88 | −63.96% |
| 2022 | 2022-12-31 | $9.19 | -$3.70 | −28.70% |
| 2021 | 2021-12-31 | $12.89 | -$1.61 | −11.10% |
| 2020 | 2020-12-31 | $14.50 | -$0.36 | −2.41% |
| 2019 | 2019-12-31 | $14.86 | -$3.21 | −17.74% |
| 2018 | 2018-12-31 | $18.07 | $5.14 | +39.74% |
| 2017 | 2017-12-31 | $12.93 | $27.36 | — |
| 2016 | 2016-12-31 | -$14.43 | -$0.64 | — |
| 2015 | 2015-12-31 | -$13.79 | — | — |
Anaptysbio quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $0.44 | -$0.68 | −60.78% |
| Q4 2025 | 2025-12-31 | $1.33 | -$1.00 | −42.90% |
| Q3 2025 | 2025-09-30 | -$1.07 | -$3.84 | — |
| Q2 2025 | 2025-06-30 | -$1.60 | -$1.96 | — |
| Q1 2025 | 2025-03-31 | $1.12 | -$0.63 | −35.99% |
| Q4 2024 | 2024-12-31 | $2.33 | -$0.99 | −29.79% |
| Q3 2024 | 2024-09-30 | $2.77 | -$1.76 | −38.79% |
| Q2 2024 | 2024-06-30 | $0.36 | -$5.24 | −93.56% |
| Q1 2024 | 2024-03-31 | $1.75 | -$5.32 | −75.27% |
| Q4 2023 | 2023-12-31 | $3.31 | -$5.88 | −63.96% |
| Q3 2023 | 2023-09-30 | $4.53 | -$5.26 | −53.73% |
| Q2 2023 | 2023-06-30 | $5.60 | -$5.18 | −48.09% |
| Q1 2023 | 2023-03-31 | $7.07 | -$4.67 | −39.74% |
| Q4 2022 | 2022-12-31 | $9.19 | -$3.70 | −28.70% |
| Q3 2022 | 2022-09-30 | $9.79 | -$4.18 | −29.93% |
| Q2 2022 | 2022-06-30 | $10.78 | -$3.28 | −23.34% |
| Q1 2022 | 2022-03-31 | $11.74 | -$2.22 | −15.89% |
| Q4 2021 | 2021-12-31 | $12.89 | -$1.61 | −11.10% |
| Q3 2021 | 2021-09-30 | $13.97 | $0.80 | +6.07% |
| Q2 2021 | 2021-06-30 | $14.06 | $0.08 | +0.59% |
| Q1 2021 | 2021-03-31 | $13.96 | -$0.73 | −4.96% |
| Q4 2020 | 2020-12-31 | $14.50 | -$0.36 | −2.41% |
| Q3 2020 | 2020-09-30 | $13.17 | -$2.36 | −15.19% |
| Q2 2020 | 2020-06-30 | $13.98 | -$2.60 | −15.69% |
| Q1 2020 | 2020-03-31 | $14.68 | -$2.65 | −15.29% |
| Q4 2019 | 2019-12-31 | $14.86 | -$3.21 | −17.74% |
| Q3 2019 | 2019-09-30 | $15.53 | -$3.15 | −16.85% |
| Q2 2019 | 2019-06-30 | $16.58 | $4.72 | +39.80% |
| Q1 2019 | 2019-03-31 | $17.34 | $4.97 | +40.18% |
| Q4 2018 | 2018-12-31 | $18.07 | $5.14 | +39.74% |
| Q3 2018 | 2018-09-30 | $18.68 | $13.74 | +277.76% |
| Q2 2018 | 2018-06-30 | $11.86 | $6.48 | +120.42% |
| Q1 2018 | 2018-03-31 | $12.37 | $6.93 | +127.41% |
| Q4 2017 | 2017-12-31 | $12.93 | $27.36 | — |
| Q3 2017 | 2017-09-30 | $4.95 | — | — |
| Q2 2017 | 2017-06-30 | $5.38 | — | — |
| Q1 2017 | 2017-03-31 | $5.44 | — | — |
| Q4 2016 | 2016-12-31 | -$14.43 | — | — |
Anaptysbio book value per share trends
Over the last five fiscal years, Anaptysbio's book value per share decreased from $14.50 to $1.33, a change of -$13.17. The latest reported quarter, Q1 2026, shows $0.44.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Anaptysbio source filings ↗